BioDelivery Sciences International Inc (NASDAQ:BDSI)

9.46
Delayed Data
As of Apr 17
 -0.56 / -5.59%
Today’s Change
7.27
Today|||52-Week Range
18.48
-21.30%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$495.0M

Company Description

BioDelivery Sciences International, Inc. is a specialty pharmaceutical company that is leveraging its novel and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties. It is focusing on developing products to meet unmet patient needs in the areas of pain management and addiction. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC.

Contact Information

BioDelivery Sciences International, Inc.
801 Corporate Center Drive
Raleigh North Carolina 27607
P:(919) 582-9050
Investor Relations:

Employees

Shareholders

Individual stakeholders9.52%
Mutual fund holders41.48%
Other institutional34.86%

Top Executives

Mark A. SirgoPresident, Chief Executive Officer & Director
Ernest R. de PaolantonioChief Financial Officer & Secretary
Niraj VasishtChief Technology Officer & SVP-Product Development
Adrian HepnerVP-Clinical Research & Regulatory Affairs
James A. McNultyTreasurer & Senior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account